Healthcare · NYSE/NASDAQ: ELV
Elevance Health, Inc.
Healthcare Plans
Market Cap $87.28B
Verdict: Average
Quality Scores
Multi-Bagger
42/100
Compounder Quality
74/100
Management Credibility
72/100
Governance
88/100
Cash Flow Quality
55/100
AI Summary
Elevance Health (formerly Anthem) has undergone a massive scaling phase, with revenue growing from $21.71B in 2016 to nearly $199.13B in 2025. While the top-line expansion is extraordinary, particularly the jump in 2021, the bottom-line profitability and cash flow generation have not scaled with equal velocity. Net income margins have compressed significantly, and the company is currently navigating a period of declining earnings despite record revenues. The transition from a regional Blue Cross Blue Shield provider to a diversified health services giant is evident, but the capital-intensive…
Top Opportunities
- Massive revenue scale exceeding $199B
- Strong market position in Blue Cross Blue Shield licenses
- Successful pivot to health services via Carelon
Top Risks
- Operating margins compressed to under 4% in 2025
- Cash flow from operations on a 3-year downward trajectory
- Increasing long-term debt levels exceeding $30B
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.